G. Bug

465 total citations
7 papers, 287 citations indexed

About

G. Bug is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, G. Bug has authored 7 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 2 papers in Genetics and 2 papers in Oncology. Recurrent topics in G. Bug's work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). G. Bug is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). G. Bug collaborates with scholars based in Germany. G. Bug's co-authors include Frédérik Damm, Arnold Ganser, Michael Heuser, Felicitas Thol, E. M. Weissinger, Oliver G. Ottmann, Christiane Schumann, W.-K. Hofmann, J. Krauter and Manfred Wichmann and has published in prestigious journals such as Haematologica, Value in Health and Biology of Blood and Marrow Transplantation.

In The Last Decade

G. Bug

7 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Bug Germany	5	235	98	87	50	36	7	287
Federica Cattina Italy	9	187 0.8×	136 1.4×	80 0.9×	44 0.9×	41 1.1×	35	282
Catharina Müller‐Thomas Germany	8	218 0.9×	145 1.5×	82 0.9×	23 0.5×	34 0.9×	19	299
Ahmad Antar Lebanon	6	269 1.1×	135 1.4×	55 0.6×	17 0.3×	51 1.4×	13	333
Maria Gracia Gonzalez Spain	7	202 0.9×	182 1.9×	63 0.7×	46 0.9×	59 1.6×	8	380
Ch. M. Zwaan Netherlands	6	301 1.3×	131 1.3×	97 1.1×	28 0.6×	29 0.8×	8	365
Francesca Buchi Italy	10	263 1.1×	210 2.1×	97 1.1×	24 0.5×	28 0.8×	12	345
Melissa Rijken Netherlands	4	260 1.1×	117 1.2×	100 1.1×	62 1.2×	34 0.9×	13	326
Mark Velangi United Kingdom	8	160 0.7×	84 0.9×	69 0.8×	15 0.3×	40 1.1×	17	251
Madlen Jentzsch Germany	13	405 1.7×	111 1.1×	104 1.2×	67 1.3×	65 1.8×	61	469
Fengkuan Yu China	7	222 0.9×	104 1.1×	67 0.8×	13 0.3×	32 0.9×	25	265

Countries citing papers authored by G. Bug

Since Specialization

Citations

This map shows the geographic impact of G. Bug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Bug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Bug more than expected).

Fields of papers citing papers by G. Bug

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Bug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Bug. The network helps show where G. Bug may publish in the future.

Co-authorship network of co-authors of G. Bug

This figure shows the co-authorship network connecting the top 25 collaborators of G. Bug. A scholar is included among the top collaborators of G. Bug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Bug. G. Bug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Becker, P. S. A., et al.. (2017). Characterization of the novel HLA‐B*49:39 allele identified in a German leukaemia patient. HLA. 90(1). 43–45. 3 indexed citations

2.

Schroeder, Thomas, Akos Czibere, Nicolaus Kröger, et al.. (2011). Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548). Biology of Blood and Marrow Transplantation. 17(2). S159–S159. 5 indexed citations

3.

Boehme, Angelika, J. Atta, Sabine Mousset, et al.. (2010). PCN47 CHANGE OF ANTIFUNGAL TREATMENT PATTERNS AND ASSOCIATED COSTS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) AFTER CHEMOTHERAPY IN A GERMAN HOSPITAL FROM 2004 TO 2006. Value in Health. 13(7). A259–A260. 2 indexed citations

4.

Thol, Felicitas, E. M. Weissinger, J. Krauter, et al.. (2010). IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica. 95(10). 1668–1674. 142 indexed citations

5.

Bornhäuser, Martin, Uwe Platzbecker, G. Bug, et al.. (2009). Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation. Haematologica. 94(11). 1613–1617. 91 indexed citations

6.

Wolf, Timo, Volker Rickerts, Schlomo Staszewski, et al.. (2007). First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe Aplastic Anemia. Haematologica. 92(4). e56–e58. 24 indexed citations

7.

Bug, G., et al.. (1996). Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells.. PubMed. 24(8). 863–7. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact